English deutsch Impressum
Sitemap Disclaimer
Company Product Investor Relations Newsroom Careers Contact
 

WILEX is developing novel cancer therapies to provide effective
and well tolerated treatment and enhance patients' quality of life.

Latest press release
24.02.2010: WILEX reports on the successful financial year 2009

Latest Ad-hoc-Announcements release
03.12.2009: WILEX AG closes capital increase

RENCAREX®
Therapeutic antibody in Phase III development

Annual Report 2009

Current Company Presentation March 2010

 

Meet WILEX!

08.-10.03.2010
BIO Europe Spring in Barcelona
08.-11.03.2010
Cowen Healthcare Conference in Boston
Conference list

 

© 2006 WILEX AG